✦ LIBER ✦

Safety and Efficacy of HMG-CoA Reductase Inhibitors for Treatment of Hyperlipidemia in Patients with HIV Infection

✍ Scribed by Scott R. Penzak; Susan K. Chuck; Gregory V. Stajich

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fluvastatin (Sandoz compound XU 62-320-

✍ S. Rywik; U. Klosiewicz-Latoszek; G. Broda; W.B. Szostak 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 119 KB

Effect of HMG-CoA reductase inhibitors o

✍ N. Nakamura; T. Hamazaki; H. Jokaji; S. Minami; M. Kobayashi 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 341 KB

Long-term safety and efficacy of combina

✍ David K. Murdock; Anthony K. Murdock; Robert W. Murdock; Karen J. Olson; Arlyne 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 121 KB

Therapeutic Change of HMG-CoA Reductase

✍ Daniel E. Hilleman; Richard L. Wurdeman; Thomas L. Lenz 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 37 KB

Incidence of adverse events with HMG-CoA

✍ Jill E. Martin; Teresa M. Cavanaugh; Leslie Trumbull; Maryetta Bass; Fredrick We 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB

Clinical efficacy of fluvastatin, a new

✍ T. Teramoto; Y. Goto 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 151 KB